Your email has been successfully added to our mailing list.

×
-0.0933879847855913 -0.0933879847855913 -0.0933879847855913 -0.0933879847855913 -0.0118971116939054 -0.0343366274727755 -0.0343366274727755 -0.0343366274727755
Stock impact report

Immuron Granted US Patent for NASH Treatment

Immuron Limited - American Depositary Shares (IMRN) 
Company Research Source: GlobeNewswire
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercialising oral immunotherapeutics for the treatment of gut-mediated diseases, is today pleased to announced that a Notice of Allowance has been received from the United States Patent and Trademarks Office (USPTO) for Immuron’s new patent application (U.S Application No. 13/817,414), entitled “Anti-LPS Enriched Immunoglobulin for Use in treatment and/or Prophylaxis of a Pathological Disorder.” The patent comprises of a total of ten allowed claims, and is principally directed to a method of treating non-alcoholic steatohepatitis (NASH) with a colostrum-based composition, as developed by Immuron. The market for NASH treatment has come under increased focus, as companies including Bristol-Myers Squibb and Pfizer have referenced efforts to bolster their product development in the sector. According to Reuters, Show less Read more
Impact Snapshot
Event Time:
IMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMRN alerts
Opt-in for
IMRN alerts

from News Quantified
Opt-in for
IMRN alerts

from News Quantified